Vericel (VCEL) Stock: Buy, Sell, or Hold?
$57.75
-1.71 (-2.87%)
▼
5d:
+11.52%
30d:
+43.47%
90d:
+30.64%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect VCEL Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (14%)
Quality Score
32/100
Position
EXTENDED
30-Day Fair Range
$38.09 – $47.18
Position: EXTENDED
Forward P/E & Valuation
61.0x
STRETCHED
vs 51.6x historical avg
Wall Street Target
$63.57
+6.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$39.44 / $59.75
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: VCEL is 22.4% above its trading range ($47.18). Market expects 5.7% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When VCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$47.47
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$29.47
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VCEL is currently trading at $57.74, which is considered extended relative to its 30-day fair value range of $38.09 to $47.18. From a valuation perspective, the stock is trading at a premium (Forward PE: 61.0) compared to its historical average (51.6). At these levels, the market is pricing in 5.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, VCEL is showing sideways momentum. Immediate support is located at $39.44, while resistance sits at $59.75.
Market Sentiment: VCEL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VCEL is showing sideways momentum. Immediate support is located at $39.44, while resistance sits at $59.75.
Market Sentiment: VCEL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$38.09 -
$47.18
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
14.3%
Trading Range & Key Levels
30-Day Trading Range
$38.09 -
$47.18
Current vs Trading Range
EXTENDED
Support Level
$39.44
Resistance Level
$59.75
Current Trend
Sideways
Technical data as of
Nov 12, 2026
Protect Your Profits
VCEL is technically overbought (RSI 76). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price significantly overextended (+22.4% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($63.57)
- NEUTRAL: PE elevated vs history but 5.7% growth expectation is conservative given 170% recent growth
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
60.97
Wall Street Target
$63.57
(+6.9%)
Revenue Growth (YoY)
26.5%
Earnings Growth (YoY)
170.0%
Profit Margin
10.3%
Valuation Premium vs History
+5.7% premium
PE vs Historical
61.0 vs 51.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.7%
(market-implied from PE analysis)
1-Year Target
$62.84
(+6%)
2-Year Target
$66.42
(+12%)
3-Year Target
$70.21
(+18%)
3-Yr Target (if PE normalizes)
(PE: 61→52)
PE COMPRESSION
$59.41
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 61.0, Growth: 33.0%)
$139.74
(+135%)
Base:
(SPY PE: 19.9, Growth: 33.0%)
$45.51
(-23%)
Bear:
(PE: 16.9, Growth: 33.0%)
$38.69
(-35%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (92x PE), but valuation improves significantly next year (61x PE) as earnings recover.
Trailing PE: 92.23 | Current EPS (TTM): $0.64
Bull Case
$98.92
(+66%)
Analyst growth 52.3%, PE expands to 101.5
Base Case
$89.93
(+51%)
Market implied 52.3%, PE stable at 92.2
Bear Case
$40.14
(-33%)
Severe decline -20.0%, PE contracts to 78.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share VCEL Analysis
Share this live VCEL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VCEL)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 7, 2026
Daily AI digest
AI Retail Discussion Summary:
Vericel reported a strong Q3 with revenue growth of 26% driven by MACI cartilage repair product and record quarter for burn care business.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:59 PM ET
Data refreshes hourly during market hours. Next update: 2:59 PM
Data refreshes hourly during market hours. Next update: 2:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 42 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 58 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Advanced VCEL Option Strategies
Professional options setups generated by AI based on today's VCEL price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VCEL Research Pages
